Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10689)
All Articles published online
|
Publishing Process of This Article
|
Jan 8, 2017 (publication date) through Jun 27, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fitian AI, Cabrera R. Disease monitoring of hepatocellular carcinoma through metabolomics. World J Hepatol 2017; 9(1): 1-17 [PMID: 28105254 DOI: 10.4254/wjh.v9.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i1/1.htm |
| Number | Citing Articles |
| 1 |
Chao-Wei Lee, Ming-Chin Yu, Gigin Lin, Jo-Chu Chiu, Meng-Han Chiang, Chang-Mu Sung, Yi-Chung Hsieh, Tony Kuo, Cheng-Yu Lin, Hsin-I Tsai. Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01885-w
|
| 2 |
Xu Han, Juan Wang, Hao Gu, Xing Liao, Miao Jiang. Predictive value of liver cirrhosis using metabolite biomarkers of bile acid in the blood. Medicine 2022; 101(4): e28529 doi: 10.1097/MD.0000000000028529
|
| 3 |
Javier Salazar, Anne Le. The Heterogeneity of Cancer Metabolism. Advances in Experimental Medicine and Biology 2021; 1311: 127 doi: 10.1007/978-3-030-65768-0_9
|
| 4 |
Munirah Alsaleh, Zoe Leftley, Thomas A. Barbera, Larry K. Koomson, Abigail Zabron, Mary M.E. Crossey, Helen L. Reeves, Matthew Cramp, Stephen Ryder, Shaun Greer, Martin Prince, Paiboon Sithithaworn, Mohamed Shariff, Narong Khuntikeo, Watcharin Loilome, Puangrat Yongvanit, Yi-Liang Shen, I. Jane Cox, Roger Williams, Christopher A. Wadsworth, Elaine Holmes, Kathryn Nash, Simon D. Taylor-Robinson. Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort. Journal of Clinical and Experimental Hepatology 2020; 10(1): 17 doi: 10.1016/j.jceh.2019.06.001
|
| 5 |
Christa Buechler, Charalampos Aslanidis. Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(5): 158658 doi: 10.1016/j.bbalip.2020.158658
|
| 6 |
Peng-Cheng Zhou, Lun-Quan Sun, Li Shao, Lun-Zhao Yi, Ning Li, Xue-Gong Fan. Establishment of a pattern recognition metabolomics model for the diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(31): 4607-4623 doi: 10.3748/wjg.v26.i31.4607
|
| 7 |
Tingting Fan, Zhuona Rong, Jianyi Dong, Juan Li, Kangwei Wang, Xinxin Wang, Huiling Li, Jun Chen, Fujin Wang, Jingyu Wang, Aiguo Wang. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice. Cancer Medicine 2017; 6(10): 2370 doi: 10.1002/cam4.1177
|
| 8 |
Jakob Johannes Meyer, Jens Dreyhaupt, Daniel Schwerdel, Thomas Jens Ettrich, Johanna Backhus, Matthias Maximilian Dollinger, Thomas Seufferlein, Andreas Wolfgang Berger. Blood-Based Targeted Metabolomics Discriminate Patients with Alcoholic Liver Cirrhosis from Those with Non-Cirrhotic Liver Damage: An Explorative Study. Digestive Diseases 2022; 40(2): 223 doi: 10.1159/000516488
|
| 9 |
Hai-Ning Liu, Hao Wu, Yan-Jie Chen, Yu-Jen Tseng, Enkhnaran Bilegsaikhan, Ling Dong, Xi-Zhong Shen, Tao-Tao Liu. Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma. Oncotarget 2017; 8(65): 108810 doi: 10.18632/oncotarget.22224
|
| 10 |
Mohamed M. Omran, Khaled Farid, Mona A. Omar, Tarek M. Emran, Fathy M. El-Taweel, Ashraf A. Tabll. A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma. Annals of Hepatology 2020; 19(2): 179 doi: 10.1016/j.aohep.2019.09.002
|
| 11 |
BaoChun Wang, Jian Xu, HaiYang Wang, ShunWu Chang, Ning Liu. Effect and Mechanism of Sophoridine to suppress Hepatocellular carcinoma in vitro and vivo. Biomedicine & Pharmacotherapy 2017; 95: 324 doi: 10.1016/j.biopha.2017.08.029
|
| 12 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
| 13 |
Wang Yang, Peng Zou, Shijun He, Haonan Cui, Zeyu Yang, Huihui An, Qing Chen, Wei Huang, Hong Guo, Jinyi Liu, Xi Ling, Jia Cao, Lin Ao. Perfluorooctane sulfonic acid impairs spermatogenesis via the liver-gut microbiota-testis axis: a central role of chenodeoxycholic acid metabolism. Journal of Advanced Research 2025; doi: 10.1016/j.jare.2025.06.037
|
| 14 |
Jiarong Hang, Yu Chen, Lukuan Liu, Liwen Chen, Jiqin Fang, Fei Wang, Miao Wang. Antitumor effect and metabonomics of niclosamide micelles. Journal of Cellular and Molecular Medicine 2022; 26(18): 4814 doi: 10.1111/jcmm.17509
|
| 15 |
Bogdan Procopet, Petra Fischer, Oana Farcau, Horia Stefanescu. Metabolomics: From liver chiromancy to personalized precision medicine in advanced chronic liver disease. World Journal of Hepatology 2018; 10(3): 371-378 doi: 10.4254/wjh.v10.i3.371
|
| 16 |
Mousumi Khatun, Ranjit Ray, Ratna B. Ray. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 103 doi: 10.1016/bs.acr.2020.10.003
|
| 17 |
Yuji Morine, Tohru Utsunomiya, Hisami Yamanaka-Okumura, Yu Saito, Shinichiro Yamada, Tetsuya Ikemoto, Satoru Imura, Shohei Kinoshita, Akiyoshi Hirayama, Yasuhito Tanaka, Mitsuo Shimada. Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis. Oncotarget 2022; 13(1): 1286 doi: 10.18632/oncotarget.28306
|
| 18 |
Serena De Matteis, Andrea Ragusa, Giorgia Marisi, Stefania De Domenico, Andrea Casadei Gardini, Massimiliano Bonafè, Anna Maria Giudetti, Javier Egea. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/7512159
|
| 19 |
Chanwoo Park, Boram Kim, Taesung Park. DeepHisCoM: deep learning pathway analysis using hierarchical structural component models. Briefings in Bioinformatics 2022; 23(5) doi: 10.1093/bib/bbac171
|
| 20 |
Sujin Park, Michael N. Hall. Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications. Experimental & Molecular Medicine 2025; 57(3): 515 doi: 10.1038/s12276-025-01415-2
|
| 21 |
Tran N. Nguyen, Ha Q. Nguyen, Duc-Hau Le, Francesca Megiorni. Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses. PLOS ONE 2020; 15(6): e0229276 doi: 10.1371/journal.pone.0229276
|
| 22 |
Samar Ebrahim Ghanem, Mohamed Abdel-Samiee, Hala El-Said, Mohamed I. Youssef, Hassan Ahmed ElZohry, Eman Abdelsameea, Inas Moaz, Sayed F. Abdelwahab, Shymaa A. Elaskary, Eman Mohammed Zaher, Marwa Lotfy Helal. Evaluation of Amino Acids Profile as Non-Invasive Biomarkers of Hepatocellular Carcinoma in Egyptians. Tropical Medicine and Infectious Disease 2022; 7(12): 437 doi: 10.3390/tropicalmed7120437
|
| 23 |
Li Gao, Ke-xin Wang, Yu-zhi Zhou, Jian-song Fang, Xue-mei Qin, Guan-hua Du. Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-017-18325-7
|
| 24 |
Ashraf Khalil, Ashraf Elfert, Samar Ghanem, Marwa Helal, Shymaa Abdelsattar, Gamalate Elgedawy, Manar Obada, Mohamed Abdel-Samiee, Hala El-Said. The role of metabolomics in hepatocellular carcinoma. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00085-9
|
| 25 |
Xu Han, Juan Wang, Hao Gu, Hongtao Guo, Yili Cai, Xing Liao, Miao Jiang. Predictive value of serum bile acids as metabolite biomarkers for liver cirrhosis: a systematic review and meta-analysis. Metabolomics 2022; 18(7) doi: 10.1007/s11306-022-01890-y
|